このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Evaluating a Mindfulness Booster Course for Healthcare Staff (MBCRCT)

2026年6月1日 更新者:Canterbury Christ Church University

A Randomized Controlled Trial of an 8-Week Mindfulness "Booster" Course for Staff: Examining Effectiveness, Mediators of Impact, and Participant Experiences

The goal of this clinical trial is to learn if a mindfulness booster course can reduce stress in healthcare staff who have previously attended a mindfulness course. The main questions it aims to answer are:

  • Is a mindfulness booster course for healthcare staff effective at reducing their stress levels?
  • Are any benefits maintained for 8 weeks?

Researchers will compare a mindfulness booster course with usual care to see if it helps to reduce stress. Participants will take part in either a mindfulness booster course or do what they usually do to look after their wellbeing. They will complete questionnaires at the beginning, middle and end of the study.

調査の概要

詳細な説明

Aims:

  1. To determine whether the mindfulness booster course for healthcare staff is effective in terms of the primary outcome (perceived stress) and secondary outcomes (wellbeing, depression, burnout, and compassion for others), and whether any benefits are maintained at follow-up.
  2. To examine whether any effects on the above-mentioned outcomes are statistically mediated by changes in amount of mindfulness practice, rumination and worry, decentering, self-compassion, and trait mindfulness.
  3. To develop an abbreviated grounded theory of the therapeutic process and outcomes of the mindfulness booster course.

Hypotheses:

  1. a) The primary hypothesis is that we will see a significantly greater decrease in the primary outcome of perceived stress at post-intervention (the primary time-point of Weeks 11-12) relative to baseline (Weeks 0-1) for the 'mindfulness-booster course plus treatment as usual (TAU)' intervention group compared to the 'TAU-only' control group.

    b) Our secondary hypothesis is that we will see significantly greater improvements in each of our secondary outcome measures at post-intervention (Weeks 11-12) relative to baseline for our intervention group compared to our control group. Improvements entail decreases in depression and burnout and increases in compassion for others and wellbeing.

    c) Our third hypothesis is that we will also see the effects detailed in (1a) and (1b) above at the follow-up time-point (Weeks 19-20).

  2. a) The relationship between group allocation (intervention vs. control) and reduction in perceived stress, from baseline to follow-up (Weeks 19-20), will be statistically mediated by changes from baseline to post-intervention in the following psychological constructs: i) increase in amount of mindfulness practice, both formal and informal; ii) reduction in rumination and worry, i.e., repetitive negative thinking; iii) increase in decentering; iv) increase in self-compassion; v) increase in trait mindfulness.

    b) The relationships specified in Hypothesis 2a will also hold true for the secondary outcomes (i.e. change from baseline to follow-up [Weeks 19-20] in wellbeing, depression, burnout and compassion for others).

    c) i) The relationship between group allocation and reduction in perceived stress will be serially statistically as follows: intervention group allocation predicts increased mindfulness practice (from baseline to post-intervention [Weeks 11-12]) which in turn predicts change in psychological mechanisms (i.e., rumination/worry, decentering, self-compassion and trait mindfulness; from baseline to post-intervention [Weeks 11-12]), which in turn predict reduced perceived stress (from baseline to follow-up [Weeks 19-20]).

    ii) The relationships specified in Hypothesis 2c-i will also hold for the secondary outcomes (i.e. change from baseline to follow-up [Weeks 19-20] in wellbeing, depression, burnout and compassion for others).

    Design Information Not Included Elsewhere in this Registration:

    After Weeks 11-12, a subsample of intervention group participants will be invited to participate in a semi-structured individual interview, with the qualitative data being collected and analysed according to grounded theory principles. This aspect of the study has the following sub-aims:

    1. To explore what processes occur during the mindfulness booster course, based on participants' experiences.
    2. To explore how these processes interact with the participants' contexts, including, but not limited to, working in healthcare.
    3. To explore how these processes and contexts interact with, and perhaps drive, any perceived impacts and outcomes of the course.

研究の種類

介入

入学 (推定)

186

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

    • West Sussex
      • Worthing、West Sussex、イギリス、BN11 1HS
        • Sussex Mindfulness Centre

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

  • 大人
  • 高齢者

健康ボランティアの受け入れ

はい

説明

Inclusion Criteria:

  • UK National Health Service staff member.
  • Has completed an 8-week mindfulness course (either MBCT, MBCT-L or MBSR). Individuals will be considered to have "completed" a mindfulness course if they attended four or more sessions.
  • Is able to make one of the planned sets of times for the booster course sessions, in case they are randomly allocated to the intervention arm.

Exclusion Criteria:

  • Currently on sick leave.
  • Planning on undertaking another 8-week mindfulness course.
  • Previously participated in the mindfulness booster course in the feasibility study.
  • Have previously found practising mindfulness distressing.

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:処理
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:なし(オープンラベル)

武器と介入

参加者グループ / アーム
介入・治療
実験的:マインドフルネスブースターコース
The mindfulness booster course will consist of eight 30-minute sessions, which participants will be asked to commit to. These will be online and usually occur weekly. Within these sessions, there will be a 15-minute mindfulness practice followed by a 15-minute discussion. This discussion time will involve reflecting on the mindfulness practice and speaking about between-session practice. Participants will be encouraged to practice mindfulness for home work between the sessions.
Participants will be encouraged to continue with whatever activities they usually undertake to manage their stress and support their wellbeing.
他の:Treatment as usual control
Participants will be encouraged to continue with whatever activities they usually undertake to manage their stress and support their wellbeing.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Change in Perceived Stress Scale score from baseline (Weeks 0-1) at Weeks 11-12.
時間枠:Baseline (Weeks 0-1) and Weeks 11-12
The 10-item Perceived Stress Scale (PSS-10) is a self-report measure of perceived stress, which produces a score ranging between 0 and 40. A higher score indicates greater perceived stress.
Baseline (Weeks 0-1) and Weeks 11-12

二次結果の測定

結果測定
メジャーの説明
時間枠
Change in Perceived Stress Scale score from baseline (Weeks 0-1) at Weeks 19-20.
時間枠:Baseline (Weeks 0-1) and Weeks 19-20
The 10-item Perceived Stress Scale (PSS-10) is a self-report measure of perceived stress, which produces a score ranging between 0 and 40. A higher score indicates greater perceived stress.
Baseline (Weeks 0-1) and Weeks 19-20
Change in 8-item Patient Health Questionnaire score from baseline (Weeks 0-1) at Weeks 11-12.
時間枠:Baseline (Weeks 0-1) and Weeks 11-12.
The 8-item Patient Health Questionnaire (PHQ-8) is a self-report measure of depression, which produces a score ranging between 0 and 24. A higher score indicates a greater level of depression symptoms.
Baseline (Weeks 0-1) and Weeks 11-12.
Change in 8-item Patient Health Questionnaire score from baseline (Weeks 0-1) at Weeks 19-20.
時間枠:Baseline (Weeks 0-1) and Weeks 19-20
The 8-item Patient Health Questionnaire (PHQ-8) is a self-report measure of depression, which produces a score ranging between 0 and 24. A higher score indicates a greater level of depression symptoms.
Baseline (Weeks 0-1) and Weeks 19-20
Change in Brief Sussex-Oxford Compassion for Others Scale score from baseline (Weeks 0-1) at Weeks 11-12.
時間枠:Baseline (Weeks 0-1) and Weeks 11-12.
The Brief Sussex-Oxford Compassion for Others Scale (SOCS-O) is a 5-item, self-report measure of compassion for others, which produces a score ranging between 5 and 25. A higher score indicates greater compassion for others.
Baseline (Weeks 0-1) and Weeks 11-12.
Change in Brief Sussex-Oxford Compassion for Others Scale score from baseline (Weeks 0-1) at Weeks 19-20.
時間枠:Baseline (Weeks 0-1) and Weeks 19-20
The Brief Sussex-Oxford Compassion for Others Scale (SOCS-O) is a 5-item, self-report measure of compassion for others, which produces a score ranging between 5 and 25. A higher score indicates greater compassion for others.
Baseline (Weeks 0-1) and Weeks 19-20
Change in Sussex Burnout Scale score from baseline (Weeks 0-1) at Weeks 11-12.
時間枠:Baseline (Weeks 0-1) and Weeks 11-12.
The Sussex Burnout Scale (SBS) is a 3-item self-report measure of burnout, which produces a score ranging between 3 and 15. A higher score indicates a greater level of burnout.
Baseline (Weeks 0-1) and Weeks 11-12.
Change in Sussex Burnout Scale score from baseline (Weeks 0-1) at Weeks 19-20.
時間枠:Baseline (Weeks 0-1) and Weeks 19-20.
The Sussex Burnout Scale (SBS) is a 3-item self-report measure of burnout, which produces a score ranging between 3 and 15. A higher score indicates a greater level of burnout.
Baseline (Weeks 0-1) and Weeks 19-20.
Change in Short Warwick-Edinburgh Mental Wellbeing Scale score from baseline (Weeks 0-1) at Weeks 11-12.
時間枠:Baseline (Weeks 0-1) and Weeks 11-12.
The Short Warwick-Edinburgh Mental Wellbeing Scale (SWEMWBS) is a 7-item self-report measure of mental wellbeing, which produces a score ranging between 7 and 35. A higher score indicates a greater level of mental wellbeing.
Baseline (Weeks 0-1) and Weeks 11-12.
Change in Short Warwick-Edinburgh Mental Wellbeing Scale score from baseline (Weeks 0-1) at Weeks 19-20.
時間枠:Baseline (Weeks 0-1) and Weeks 19-20.
The Short Warwick-Edinburgh Mental Wellbeing Scale (SWEMWBS) is a 7-item self-report measure of mental wellbeing, which produces a score ranging between 7 and 35. A higher score indicates a greater level of mental wellbeing.
Baseline (Weeks 0-1) and Weeks 19-20.

その他の成果指標

結果測定
メジャーの説明
時間枠
Change in the 15-item Five-Facet Mindfulness Questionnaire from baseline (Weeks 0-1) at Weeks 11-12.
時間枠:Baseline (Weeks 0-1) and Weeks 11-12.
The 15-item Five-Facet Mindfulness Questionnaire (FFMQ-15) is a self-report measure of mindfulness, which produces a score ranging between 15 and 75. A higher score indicates a greater level of mindfulness.
Baseline (Weeks 0-1) and Weeks 11-12.
Change in the Brooding Subscale of the Ruminative Response Scale from baseline (Weeks 0-1) at Weeks 11-12.
時間枠:Baseline (Weeks 0-1) and Weeks 11-12.
The 5-item Brooding Subscale of the Ruminative Response Scale (RRS-B) is a self-report measure of brooding rumination, which produces a score ranging between 5 and 20. A higher score indicates a greater level of brooding rumination.
Baseline (Weeks 0-1) and Weeks 11-12.
Change in the 8-item version of the Penn State Worry Questionnaire from baseline (Weeks 0-1) at Weeks 11-12.
時間枠:Baseline (Weeks 0-1) and Weeks 11-12.
The 8-item Penn State Worry Questionnaire (PSWQ-A) is a self-report measure of worry, which produces a score ranging between 8 and 40. A higher score indicates a greater level of worry.
Baseline (Weeks 0-1) and Weeks 11-12.
Change in the Decentering Scale of the Experiences Questionnaire from baseline (Weeks 0-1) at Weeks 11-12.
時間枠:Baseline (Weeks 0-1) and Weeks 11-12.
The 11-item Decentering Scale of the Experiences Questionnaire (EQ-D) is a self-report measure of decentering, which produces a score ranging between 11 and 55. A higher score indicates a greater ability to decenter.
Baseline (Weeks 0-1) and Weeks 11-12.
Change in Brief Sussex-Oxford Compassion to Self Scale score from baseline (Weeks 0-1) at Weeks 11-12.
時間枠:Baseline (Weeks 0-1) and Weeks 11-12.
The Brief Sussex-Oxford Compassion to Self Scale (SOCS-S) is a 5-item, self-report measure of compassion for the self, which produces a score ranging between 5 and 25. A higher score indicates greater compassion towards oneself.
Baseline (Weeks 0-1) and Weeks 11-12.
Change in the average amount of time spent practicing mindfulness from baseline (Weeks 0-1) at Weeks 11-12.
時間枠:Baseline (Weeks 0-1) and Weeks 11-12.
A bespoke, self-report questionnaire will measure the amount of mindfulness practice undertaken, on average, per week, in minutes. Separate averages will be calculated for formal and informal mindfulness practice.
Baseline (Weeks 0-1) and Weeks 11-12.

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

捜査官

  • 主任研究者:Fergal W Jones, PhD, PsychD、Canterbury Christ Church University & Sussex Partnership NHS Foundation Trust
  • スタディチェア:Clara Strauss, PhD, DClinPsychol、Sussex Partnership NHS Foundation Trust & University of Sussex
  • スタディディレクター:Becky Pearse, BA, MSc、Canterbury Christ Church University & Surrey and Borders Partnership NHS Foundation Trust
  • スタディディレクター:Becky Pfaff, BSc, MSc、Canterbury Christ Church University & Surrey and Borders Partnership NHS Foundation Trust
  • スタディディレクター:Lila Maleviti, BSc, MSc、Canterbury Christ Church University & Surrey and Borders Partnership NHS Foundation Trust

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2026年5月13日

一次修了 (推定)

2027年3月1日

研究の完了 (推定)

2027年5月1日

試験登録日

最初に提出

2026年4月24日

QC基準を満たした最初の提出物

2026年4月24日

最初の投稿 (実際)

2026年5月1日

学習記録の更新

投稿された最後の更新 (実際)

2026年6月3日

QC基準を満たした最後の更新が送信されました

2026年6月1日

最終確認日

2026年5月1日

詳しくは

本研究に関する用語

その他の研究ID番号

  • ETH2526-0057
  • IRAS 366211 (その他の識別子:Health Research Authority (HRA) UK)

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

はい

IPD プランの説明

All outcome measure IPD will be made publicly available. Some or all demographic IPD may be excluded to prevent jigsaw identification of participants. An assessmment of what, if any, demographic IPD can be included will be made once the data have been collected and the risk of participant identification assessed.

IPD 共有時間枠

These will be made available after the study findings have been published in peer reviewed journals and, in any event, no more than 3 years after study completion.

IPD 共有アクセス基準

These will be made publicly available on the internet at access at https://pure.canterbury.ac.uk/en/persons/fergal-jones-2/

IPD 共有サポート情報タイプ

  • STUDY_PROTOCOL

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する